Gene Set: GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP

Standard name GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP
Systematic name M7211
Brief description Genes up-regulated inmouse embryonic fibroblasts (MEF): control versus LPS and heat shock.
Full description or abstract To clarify inflammatory genes whose expression is suppressed at high temperatures, we performed comprehensive analysis of gene expression by using a DNA microarray. Two independent primary cultures of mouse embryo fibroblasts (MEF1 and MEF2) were treated with LPS for 4 hours, or treated with LPS for 4 hours after the pretreatment with heat shock at 42?C for 1 hour, and we identified 100 genes that undergo more than a 3-fold increase with LPS treatment. Remarkably, 86 genes (86%) underwent less than a 2-fold increase after combined treatments with heat shock and LPS in MEF1 and MEF2 cells.
Collection C7: immunologic signature gene sets
      IMMUNESIGDB: ImmuneSigDB gene sets
Source publication Pubmed 20018623   Authors: Takii R,Inouye S,Fujimoto M,Nakamura T,Shinkawa T,Prakasam R,Tan K,Hayashida N,Ichikawa H,Hai T,Nakai A
Exact source GSE16266_3079_200_UP
Related gene sets (show 5 additional gene sets from the source publication)

(show 125 gene sets from the same authors)
External links  
Filtered by similarity
Organism Mus musculus
Contributed by Jernej Godec (Dana-Farber Cancer Institute)
Source platform HUMAN_GENE_SYMBOL
Dataset references (show 1 datasets)
Download gene set format: grp | text | gmt | gmx | xml
Compute overlaps (show collections to investigate for overlap with this gene set)
Compendia expression profiles GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Advanced query Further investigate these 200 genes
Gene families Categorize these 200 genes by gene family
Show members (show 200 members mapped to 200 genes)
Version history 7.3: Moved to ImmuneSigDB sub-collection.

See MSigDB license terms here. Please note that certain gene sets have special access terms.